Skip to main content
Top
Published in: Archives of Virology 5/2009

01-05-2009 | Original Article

Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants

Authors: Alejandro López-Saavedra, Leticia González-Maya, Sergio Ponce-de-León, Alejandro García-Carrancá, Alejandro Mohar, Marcela Lizano

Published in: Archives of Virology | Issue 5/2009

Login to get access

Abstract

Cervical cancer incidence remains highly frequent in developing countries. It is possible that populations of these countries are exposed to more oncogenic human papillomavirus (HPV) variants. Functional differences among high-risk HPV variants have been described, suggesting repercussions on their oncogenic potential. In this report, we demonstrate that the long control region (LCR) of HPV18 variants has distinct transcriptional activities in different cervical cancer cell lines. African (Af)-LCR possessed the lowest transcriptional activity; its sequence harbors the highest number of nucleotide changes among the HPV18 variants analyzed. Some of these embedded in identified transcription-factor-binding sites, suggesting a less aggressive biological activity possibly involved in a slower progression of cervical lesions. Asian-Amerindian LCR showed distinct activities among cell types, while European LCR activity was similar in cell lines tested. Despite multiple nucleotide substitutions found in HPV18 E2 variant genes, their repressive activities over homologous LCRs were not distinct among variants.
Literature
1.
go back to reference Muñoz N (2000) Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19:1–5PubMedCrossRef Muñoz N (2000) Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19:1–5PubMedCrossRef
2.
go back to reference Calleja-Macias IE, Kalantari M, Huh J, Ortiz-Lopez R, Rojas-Martinez A, Gonzalez-Guerrero JF, Williamson AL, Hagmar B, Wiley DJ et al (2004) Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology 319:315–323PubMedCrossRef Calleja-Macias IE, Kalantari M, Huh J, Ortiz-Lopez R, Rojas-Martinez A, Gonzalez-Guerrero JF, Williamson AL, Hagmar B, Wiley DJ et al (2004) Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology 319:315–323PubMedCrossRef
3.
go back to reference Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136PubMedCrossRef Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136PubMedCrossRef
4.
go back to reference zur Hausen H (1994) Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 186:131–156PubMed zur Hausen H (1994) Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 186:131–156PubMed
5.
go back to reference Butz K, Hoppe-Seyler F (1993) Transcriptional control of human papillomavirus oncogene expression: composition of HPV type 18 upstream regulatory region. J Virol 67:6476–6486PubMed Butz K, Hoppe-Seyler F (1993) Transcriptional control of human papillomavirus oncogene expression: composition of HPV type 18 upstream regulatory region. J Virol 67:6476–6486PubMed
6.
go back to reference Stünkel W, Bernard HU (1999) The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J Virol 73:1918–1930PubMed Stünkel W, Bernard HU (1999) The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J Virol 73:1918–1930PubMed
7.
go back to reference Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LS, Li BF, Bernard HU (2004) The human papillomavirus 18 genome is efficiently targeted by cellular DNA methylation. Virology 324:483–492PubMedCrossRef Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LS, Li BF, Bernard HU (2004) The human papillomavirus 18 genome is efficiently targeted by cellular DNA methylation. Virology 324:483–492PubMedCrossRef
8.
go back to reference Tan SH, Leong LEC, Walker PA, Bernard HU (1994) The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol 68:6411–6420PubMed Tan SH, Leong LEC, Walker PA, Bernard HU (1994) The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol 68:6411–6420PubMed
9.
go back to reference Thierry F, Howley PM (1991) Functional analysis of E2-mediated repression of the HPV 18 P105 promoter. New Biol 3:90–100PubMed Thierry F, Howley PM (1991) Functional analysis of E2-mediated repression of the HPV 18 P105 promoter. New Biol 3:90–100PubMed
10.
go back to reference Dowhanick JJ, McBride AA, Howley PM (1995) Suppression of cellular proliferation by the papillomavirus E2 protein. J Virol 69:7791–7799PubMed Dowhanick JJ, McBride AA, Howley PM (1995) Suppression of cellular proliferation by the papillomavirus E2 protein. J Virol 69:7791–7799PubMed
11.
go back to reference Desaintes C, Demeret C, Goyat S, Yaniv M, Thierry F (1997) Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J 16:504–514PubMedCrossRef Desaintes C, Demeret C, Goyat S, Yaniv M, Thierry F (1997) Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J 16:504–514PubMedCrossRef
12.
go back to reference Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP (1996) Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 88:1361–1368PubMedCrossRef Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP (1996) Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 88:1361–1368PubMedCrossRef
13.
go back to reference Bulk S, Berkhof J, Bulkmans NW, Zielinski GD, Rozendaal L, Van Kemenade FJ, Snidjers PJ, Meijer CJ (2006) Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to woman with normal cytology in The Netherlands. Br J Cancer 94:171–175PubMedCrossRef Bulk S, Berkhof J, Bulkmans NW, Zielinski GD, Rozendaal L, Van Kemenade FJ, Snidjers PJ, Meijer CJ (2006) Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to woman with normal cytology in The Netherlands. Br J Cancer 94:171–175PubMedCrossRef
14.
go back to reference Burk RD, Terai M, Gravitt PE, Briton LA, Kurman RJ, Barnes WA, Greenberg MD, Hadjimichael OC, Fu L et al (2003) Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 63:7215–7220PubMed Burk RD, Terai M, Gravitt PE, Briton LA, Kurman RJ, Barnes WA, Greenberg MD, Hadjimichael OC, Fu L et al (2003) Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 63:7215–7220PubMed
15.
go back to reference Lizano M, Berumen J, Guido MC, Casas L, Garcia-Carranca A (1997) Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J Natl Cancer Inst 89:1227–1231PubMedCrossRef Lizano M, Berumen J, Guido MC, Casas L, Garcia-Carranca A (1997) Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J Natl Cancer Inst 89:1227–1231PubMedCrossRef
16.
go back to reference McLachlin CM, Tate JE, Zitz JC, Sheets EE, Crum CP (1994) Human papillomavirus type 18 and intraepithelial lesions of the cervix. Am J Pathol 144:141–147PubMed McLachlin CM, Tate JE, Zitz JC, Sheets EE, Crum CP (1994) Human papillomavirus type 18 and intraepithelial lesions of the cervix. Am J Pathol 144:141–147PubMed
17.
go back to reference Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara-Nazos P, Labropoulou V, Pfister H, Tay SK, ter Meulen J et al (1993) Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 67:6424–6431PubMed Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara-Nazos P, Labropoulou V, Pfister H, Tay SK, ter Meulen J et al (1993) Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 67:6424–6431PubMed
18.
go back to reference Chen Z, DeSalle R, Schiffman M, Herrero R, Burk R (2009) Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. J Virol 83:1443–1445PubMedCrossRef Chen Z, DeSalle R, Schiffman M, Herrero R, Burk R (2009) Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. J Virol 83:1443–1445PubMedCrossRef
19.
go back to reference Da Costa MM, Hogeboom CJ, Holly EA, Palefsky JM (2002) Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis 185:1229–1237PubMedCrossRef Da Costa MM, Hogeboom CJ, Holly EA, Palefsky JM (2002) Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis 185:1229–1237PubMedCrossRef
20.
go back to reference Giannoudis A, Duin M, Snijders PJ, Herrington CS (2001) Variation in the E2-binding domain of HPV-16 is associated with high-grade squamous intraepithelial lesions of the cervix. Br J Cancer 84:1058–1063PubMedCrossRef Giannoudis A, Duin M, Snijders PJ, Herrington CS (2001) Variation in the E2-binding domain of HPV-16 is associated with high-grade squamous intraepithelial lesions of the cervix. Br J Cancer 84:1058–1063PubMedCrossRef
21.
go back to reference Kammer C, Warthorst U, Torrez-Martinez N, Wheeler CM, Pfister H (2000) Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol 81:1975–1981PubMed Kammer C, Warthorst U, Torrez-Martinez N, Wheeler CM, Pfister H (2000) Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol 81:1975–1981PubMed
22.
go back to reference Veress G, Murvai M, Szarka K, Juhász A, Kónya J, Gergely L (2001) Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region. E J Cancer 37:1946–1952CrossRef Veress G, Murvai M, Szarka K, Juhász A, Kónya J, Gergely L (2001) Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region. E J Cancer 37:1946–1952CrossRef
23.
go back to reference Sichero L, Franco E, Villa LL (2005) Different P105 promoter activities among natural variants of human papillomavirus type 18. J Infect Dis 191:739–742PubMedCrossRef Sichero L, Franco E, Villa LL (2005) Different P105 promoter activities among natural variants of human papillomavirus type 18. J Infect Dis 191:739–742PubMedCrossRef
24.
go back to reference Hecht JL, Kadish AS, Jiang G (1995) Genetic characterization of human papillomavirus 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int J Cancer 60:369–376PubMedCrossRef Hecht JL, Kadish AS, Jiang G (1995) Genetic characterization of human papillomavirus 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int J Cancer 60:369–376PubMedCrossRef
25.
go back to reference Lizano M, De la Cruz-Hernandez E, Carrillo-Garcia A, Garcia-Carranca A, Ponce-de-Leon-Rosales S, Duenas-Gonzalez A, Hernandez-Hernadez DM, Mohar A (2006) Distribution of HPV16 and 18 intratipic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol Oncol 102:230–235PubMedCrossRef Lizano M, De la Cruz-Hernandez E, Carrillo-Garcia A, Garcia-Carranca A, Ponce-de-Leon-Rosales S, Duenas-Gonzalez A, Hernandez-Hernadez DM, Mohar A (2006) Distribution of HPV16 and 18 intratipic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol Oncol 102:230–235PubMedCrossRef
26.
go back to reference De la Cruz-Hernández E, García-Carrancá A, Mohar-Betancourt A, Dueñas-González A, Contreras-Paredes A, Pérez-Cardenas E, Herrera-Goepfert R, Lizano-Soberon M (2005) Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences. J Gen Virol 86:2459–2468CrossRef De la Cruz-Hernández E, García-Carrancá A, Mohar-Betancourt A, Dueñas-González A, Contreras-Paredes A, Pérez-Cardenas E, Herrera-Goepfert R, Lizano-Soberon M (2005) Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences. J Gen Virol 86:2459–2468CrossRef
27.
go back to reference Demeret C, Yaniv M, Thierry F (1994) The E2 transcriptional repressor can compensate for SP1 activation of the human papillomavirus type 18 early promoter. J Virol 68:7075–7082PubMed Demeret C, Yaniv M, Thierry F (1994) The E2 transcriptional repressor can compensate for SP1 activation of the human papillomavirus type 18 early promoter. J Virol 68:7075–7082PubMed
28.
go back to reference Hidalgo A, Monroy A, Arana RM, Taja L, Vazquez G, Salcedo M (2003) Chromosomal imbalances in four new uterine cervix carcinoma derived cell lines. BMC Cancer 3:1–5CrossRef Hidalgo A, Monroy A, Arana RM, Taja L, Vazquez G, Salcedo M (2003) Chromosomal imbalances in four new uterine cervix carcinoma derived cell lines. BMC Cancer 3:1–5CrossRef
29.
go back to reference Judge GG, Griffiths WE, Hill RC, Lûtkepoul H, Lee TC (1985) The theory and practice of econometrics, 2nd edn. Wiley, New York Judge GG, Griffiths WE, Hill RC, Lûtkepoul H, Lee TC (1985) The theory and practice of econometrics, 2nd edn. Wiley, New York
30.
go back to reference StataCorp (2005) Stata statistical software: release 9. StataCorp LP, College Station StataCorp (2005) Stata statistical software: release 9. StataCorp LP, College Station
31.
go back to reference Siegel AF (1988) Statistics and data analysis an introduction. Wiley, New York Siegel AF (1988) Statistics and data analysis an introduction. Wiley, New York
32.
go back to reference Arias-Pulido H, Peyton CL, Torres-Martinez N, Anderson DN, Wheeler CM (2005) Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions. Virology 338:22–34PubMedCrossRef Arias-Pulido H, Peyton CL, Torres-Martinez N, Anderson DN, Wheeler CM (2005) Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions. Virology 338:22–34PubMedCrossRef
33.
go back to reference Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL (2007) High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 120:1763–1768PubMedCrossRef Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL (2007) High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 120:1763–1768PubMedCrossRef
34.
go back to reference De Bôer MA, Peters LA, Aziz MF, Siregar B, Cornain S, Vrede MA, Jordanova ES, Fleuren GJ (2005) Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int J Cancer 114:422–425PubMedCrossRef De Bôer MA, Peters LA, Aziz MF, Siregar B, Cornain S, Vrede MA, Jordanova ES, Fleuren GJ (2005) Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int J Cancer 114:422–425PubMedCrossRef
35.
go back to reference Watts KJ, Thompson CH, Cossart YE, Rose BR (2001) Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia. J Clin Microbiol 39:2009–2014PubMedCrossRef Watts KJ, Thompson CH, Cossart YE, Rose BR (2001) Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia. J Clin Microbiol 39:2009–2014PubMedCrossRef
36.
go back to reference Meissner JD (1999) Nucleotide sequences and further characterization of human papillomavirus DNA present in the CasKi, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol 80:1725–1733PubMed Meissner JD (1999) Nucleotide sequences and further characterization of human papillomavirus DNA present in the CasKi, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol 80:1725–1733PubMed
37.
go back to reference Caceres-Cortez JR, Alvarado-Moreno JA, Waga K, Rangel-Corona R, Monroy-Garcia A, Rocha-Zavaleta L, Urdiales-Ramos J, Weiss-Steider B, Haman A, Brousseau R, Hoang T (2001) Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias. Cancer Res 61:6281–6289 Caceres-Cortez JR, Alvarado-Moreno JA, Waga K, Rangel-Corona R, Monroy-Garcia A, Rocha-Zavaleta L, Urdiales-Ramos J, Weiss-Steider B, Haman A, Brousseau R, Hoang T (2001) Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias. Cancer Res 61:6281–6289
38.
go back to reference Veress G, Szarka K, Dong XP, Gersely L, Pfister H (1999) Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol 80:1035–1043PubMed Veress G, Szarka K, Dong XP, Gersely L, Pfister H (1999) Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol 80:1035–1043PubMed
39.
go back to reference Lee D, Lee B, Kim J, Kim DW, Choe J (2000) cAMP response element-binding protein-binding protein binds to human papillomvirus E2 protein and activates E2-dependant transcription. J Biol Chem 275:7045–7051PubMedCrossRef Lee D, Lee B, Kim J, Kim DW, Choe J (2000) cAMP response element-binding protein-binding protein binds to human papillomvirus E2 protein and activates E2-dependant transcription. J Biol Chem 275:7045–7051PubMedCrossRef
40.
go back to reference Steger G, Schnabel C, Schmidt HM (2002) The hinge region of the HPV type 8 E2 protein activates the human p21WAF1/CIP1 promoter via interaction with Sp1. J Gen Virol 83:503–510PubMed Steger G, Schnabel C, Schmidt HM (2002) The hinge region of the HPV type 8 E2 protein activates the human p21WAF1/CIP1 promoter via interaction with Sp1. J Gen Virol 83:503–510PubMed
41.
go back to reference Hadaschik D, Hinterkeuser K, Oldak M, Pfister HJ, Smola-Hess S (2003) The Papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J Virol 77:5253–5265PubMedCrossRef Hadaschik D, Hinterkeuser K, Oldak M, Pfister HJ, Smola-Hess S (2003) The Papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J Virol 77:5253–5265PubMedCrossRef
Metadata
Title
Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants
Authors
Alejandro López-Saavedra
Leticia González-Maya
Sergio Ponce-de-León
Alejandro García-Carrancá
Alejandro Mohar
Marcela Lizano
Publication date
01-05-2009
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 5/2009
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-009-0362-4

Other articles of this Issue 5/2009

Archives of Virology 5/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine